Device Trial Radar · NCT05997381
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
268
Planned (sponsor's estimate)
Start
Jan 5, 2024
Primary completion
May 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- CONMED CorporationPublic (CNMD)
- Sponsor type
- Industry
- First posted
- Aug 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to evaluate the safety and effectiveness of arthroscopic rotator cuff repair augmented with the BioBrace® Implant vs. arthroscopic rotator cuff repair alone in subjects requiring surgical intervention for a full-thickness rotator cuff tear.
Conditions
- Rotator Cuff Tears
Interventions
Arthroscopic rotator cuff repair with BioBrace® Implant augmentation.Device
An arthroscopic rotator cuff repair will be performed and augmented with the BioBrace® Implant. The BioBrace® Implant is intended for use in surgical procedures for reinforcement of soft tissue where weakness exists. It is a bioresorbable, biocomposite scaffold composed of a highly porous collagen sponge and reinforced with poly-L-lactic-acid (PLLA). When used in rotator cuff repairs, it is placed on top of the tendons to augment and reinforce the underlying repair. The BioBrace® is designed to mechanically and biologically augment weakened or torn soft tissue and can be integrated into surgeons' standard of care rotator cuff repair techniques.
Arthroscopic rotator cuff repairProcedure
An arthroscopic rotator cuff repair is performed using standard surgical procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 6 Month Retear RateTime frame: 6 months post-op
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ConMed
New Haven, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.